JO2615B1 - Benzimidazole compound - Google Patents
Benzimidazole compoundInfo
- Publication number
- JO2615B1 JO2615B1 JO200697A JOP20060097A JO2615B1 JO 2615 B1 JO2615 B1 JO 2615B1 JO 200697 A JO200697 A JO 200697A JO P20060097 A JOP20060097 A JO P20060097A JO 2615 B1 JO2615 B1 JO 2615B1
- Authority
- JO
- Jordan
- Prior art keywords
- group
- represent
- hydrogen atom
- gastric acid
- acid secretion
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention is directed to providing a novel compound useful as a therapeutic agent or prophylactic agent for acid-related diseases, which highly inhibits gastric acid secretion, more persistently inhibits gastric acid secretion, and is appropriately physicochemically stable. A compound represented by the formula (1) where R1 and R3 is the same or different and each represent a hydrogen atom or a C1-C6 alkyl group,R2 represents a (5, 5-dimethyl-1,3-dioxan-2-yl)methoxy group or the like; R4, R5, R6 and R7 each represent a hydrogen atom, halogen atom, Cl-C6 alkyl group, Cl-C6 haloalkyl group, Cl-C6 alkoxy group or Cl-C6 haloalkoxy group, and W1 represents a single bond, methylene group or ethylene group, or a salt thereof, or a solvate of these.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005117643 | 2005-04-15 | ||
| US67584805P | 2005-04-29 | 2005-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO2615B1 true JO2615B1 (en) | 2011-11-01 |
Family
ID=39307941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO200697A JO2615B1 (en) | 2005-04-15 | 2006-04-12 | Benzimidazole compound |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN101160306B (en) |
| JO (1) | JO2615B1 (en) |
| MY (1) | MY151167A (en) |
| SA (1) | SA06270095B1 (en) |
| TW (1) | TWI439270B (en) |
| ZA (1) | ZA200708803B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102942523A (en) * | 2012-12-05 | 2013-02-27 | 寿光富康制药有限公司 | Preparation method of omeprazole intermediate 2,3,5-trimethylpyridyl-N-oxide |
| US8962660B2 (en) * | 2013-03-14 | 2015-02-24 | Bristol-Myers Squibb Company | Oxabicyclo [2.2.2] acid GPR120 modulators |
| US10307748B2 (en) * | 2014-12-26 | 2019-06-04 | The University Of Tokyo | Method for producing proton pump inhibitor compound having optical activity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8300736D0 (en) * | 1983-02-11 | 1983-02-11 | Haessle Ab | NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS |
-
2006
- 2006-04-07 MY MYPI20061596 patent/MY151167A/en unknown
- 2006-04-12 SA SA6270095A patent/SA06270095B1/en unknown
- 2006-04-12 JO JO200697A patent/JO2615B1/en active
- 2006-04-14 TW TW95113357A patent/TWI439270B/en not_active IP Right Cessation
- 2006-04-17 CN CN2006800126056A patent/CN101160306B/en active Active
- 2006-04-17 ZA ZA200708803A patent/ZA200708803B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI439270B (en) | 2014-06-01 |
| TW200716112A (en) | 2007-05-01 |
| CN101160306A (en) | 2008-04-09 |
| ZA200708803B (en) | 2009-04-29 |
| CN101160306B (en) | 2011-11-02 |
| SA06270095B1 (en) | 2012-01-24 |
| MY151167A (en) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074057L (en) | 2,4-Diaminopyridopyrimidine derivatives and their use as mTOR inhibitors | |
| EA200801608A1 (en) | DERIVATIVES OF BENZIMIDAZOLONIC CARBONIC ACID | |
| NO20092770L (en) | Novel aminopyrimidine derivatives as PLK1 inhibitors | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| NO20091141L (en) | Pyrido (2,3-D) pyrimidinone compounds and their use as P13 inhibitors | |
| MY153045A (en) | Oxopyrazine derivative and herbicide | |
| NO20051411L (en) | Pyrazole derivatives, medical compositions containing them, medical uses thereof and intermediates for their preparation | |
| EA200601830A1 (en) | ORT-SUBSTITUTED ARYL OR HETEROARYL AMIDAL COMPOUNDS | |
| NO20092286L (en) | Nitrogen-containing heterocyclic compounds and their use | |
| NO331165B1 (en) | Derivatives of dioxane-2-alkylcarbamates, processes for their preparation and use thereof for the preparation of medicaments | |
| NO20075904L (en) | benzimidazole | |
| NO20070089L (en) | DPP-IV inhibitors | |
| NO20076006L (en) | acetylene Derivatives | |
| WO2011004162A3 (en) | 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer | |
| EA200701779A1 (en) | DERIVATIVES (1,5-DIPHENYL-1N-PYRAZOL-3-IL) OXADIAZOLE, THEIR RECEIVING AND THEIR USE IN THERAPY | |
| MX2010002662A (en) | Spirocyclic aminoquinolones as gsk-3 inhibitors. | |
| MX2016006685A (en) | N-acylimino heterocyclic compounds. | |
| EA200700360A1 (en) | NEW AMIDA HYDROCYCLIC CARBONIC ACID DERIVATIVES | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| WO2009118473A3 (en) | Azetidine-derived compounds, preparation method therefor and therapeutic use of same | |
| MX2010001566A (en) | Aminopyrazole amide derivative. | |
| DE502006008710D1 (en) | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICAMENT | |
| WO2008136378A1 (en) | Novel sulfonamide derivative and salt thereof | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
| MY161992A (en) | Novel tetrahydroisoquinoline derivative |